Testing new energy pulses for atrial fibrillation treatment
Part of Heart & circulation clinical trials.
This trial tests a new way to deliver energy (FARAPULSE PFA system) to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to see if these new waveforms can safely and effectively stop AF symptoms and improve quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with persistent or paroxysmal atrial fibrillation (AF), confirmed by a doctor and an ECG or heart monitor.
- You are willing and able to give your consent and attend all follow-up visits.
- Your left atrium is not too large (based on an imaging test).
- You have not had any prior surgery or procedure on the heart's upper chambers (atria) for arrhythmia, except for certain right-sided ones.
- You do not have a pacemaker, defibrillator, or certain other heart devices.
- You do not have certain other heart conditions, like severe valve disease, heart failure, or a history of dangerous fast heart rhythms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new tool called FARAFLEX that uses pulsed electrical energy to treat atrial fibrillation (an irregular heart rhythm). The goal is to see if this method can safely stop AF symptoms in people whose medications haven't worked.
This study tests a new way to treat atrial fibrillation using targeted electrical pulses (pulsed field ablation) instead of heat or cold. The goal is to improve safety and outcomes for people with paroxysmal or persistent AF.
This study tests a new device (FARAFLEX) that uses pulsed field energy to treat atrial fibrillation (AFib). You may qualify if you have persistent or paroxysmal AFib symptoms and have not had a prior ablation.
This trial tests a newer treatment called pulsed field ablation (PFA) for people with paroxysmal atrial fibrillation (AF), where the heart's rhythm is irregular and comes and goes on its own within 7 days. The goal is to see if PFA can restore a normal heart rhythm while better protecting the heart's left atrial function, which helps pump blood effectively. If you have AF and medications haven't worked, this could be an option to discuss with your doctor.
This trial tests a new device that uses pulsed electric fields to treat atrial fibrillation (AF), a type of irregular heartbeat. It aims to see if this approach is safe and effective for people with AF that comes and goes or lasts for a short time.
This study tests a new device called PFLotus for people with persistent atrial fibrillation (AF), a type of irregular heartbeat. The goal is to see if it can help restore a normal heart rhythm in people who haven't gotten better with medicine.
Hear when a new Paroxysmal Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.